Transcription of Biopharmaceutical Research & Development
{{id}} {{{paragraph}}}
The Process Behind New MedicinesBiopharmaceutical Research & Development : OUR INDUSTRY IS POISED TO TRANSLATE OUR MOST PROMISING SCIENTIFIC BREAKTHROUGHS INTO MEANINGFUL TREATMENTS CAPABLE OF TACKLING THE MOST URGENT AND VEXING MEDICAL CHALLENGES OF OUR TIMES. WE STAND COMMITTED TO DRIVING PROGRESS FOR PATIENTS TODAY AND HOPE FOR TOMORROW. - KENNETH C. FRAZIER, CHAIRMAN & CEO, MERCKPHASE IPHASE IIPHASE IIIPHASE IVIND SUBMITTEDNDA/BLA SUBMITTEDFDA APPROVALTENSHUNDREDSTHOUSANDSNUMBER OF VOLUNTEERSTHE Biopharmaceutical Research AND Development PROCESSKey: IND: Investigational New Drug Application, NDA: New Drug Application, BLA: Biologics License ApplicationPOTENTIAL NEW MEDICINES1 FDA-APPROVEDMEDICINEBASICRESEARCHDRUGDIS COVERYCLINICAL TRIALSFDA
to enhance computational capacity are enabling researchers ... approaches before going into the laboratory to develop potential drug candidates, increasing the efficiency and effectiveness of the R&D process. ... investigators are already thinking about the final product, and how it will be
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}